METHODS
Patients. The study was performed in the medical intensive care unit (ICU) of a 2,000-bed tertiary-level university hospital. Between October 2002 and January 2003, all patients admitted to the ICU were enrolled consecutively in the study if they fulfilled the criteria for severe sepsis, as defined by the American College of Chest Physicians/Society of Critical Care Medicine consensus conference (13) . Patients were eligible for this study if they had a known or suspected infection on the basis of clinical data at the time of screening and if they met the following criteria: three or more signs of systemic inflammation and sepsisinduced dysfunction of at least one organ or system. Patients with liver cirrhosis, terminalstage cancer, history of hyperlipidemia, or receipt of total parenteral nutrition at the time of blood sampling were excluded. Informed written consent was obtained from the patient or his/her legal representatives. The Institutional Review Board of the National Taiwan University Hospital approved the study.
Data Collection. Patients were followed for at least 30 days after recruitment or until death. Baseline characteristics, including demographic data, organ function, disease severity, causative microorganisms, and blood chemistry analysis results, were recorded within 24 hrs after meeting the criteria for severe sepsis. Severity of the disease was assessed using the Acute Physiology and Chronic Health Evaluation II (APACHE II) score (14) , and dysfunction of organ systems was defined as previously described (15) . Hos-*See also p. 1859. From the Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch (J-YC), Douliu, Taiwan; and Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University Medical College (J-SJ, C-JY, P-CY), Taipei, Taiwan.
The authors have no financial interests to disclose. Supported, in part, by grant NTUH-93S016 from the National Taiwan University Hospital, Taipei, Tai (16, 17) . Microbiological culture results were assessed daily from the start of observation until day 30. Fasting blood samples were obtained in the morning on days 1-4, 7, and 14 of severe sepsis and were allowed to clot by refrigeration (4°C). The serum was separated and immediately stored at Ϫ80°C until analysis. Total cholesterol and triglyceride levels were measured enzymatically using kits (Denka Seiken, Tokyo, Japan). HDL and LDL cholesterol concentrations were measured by the homogeneous method (18, 19) using kits (Denka Seiken, Tokyo, Japan). Apolipoprotein A-I (Apo-AI), Apo-B, and Apo-E levels were measured turbidimetrically with a polyclonal Apo-AI, Apo-B, or Apo-E antiserum (Daiichi Pure Chemical, Tokyo, Japan), respectively. Tumor necrosis factor (TNF)-␣ and interleukin-6 concentrations were measured on day 1 by an enzyme-linked immunosorbent assay (R & D Systems, Minneapolis, MN).
TNF-␣ Induction Assay. The ability of HDL to attenuate LPS-induced TNF-␣ production was studied using the THP-1 cell line cultured in RPMI-1640 medium at 37°C and 5% CO 2 .
The cells were plated at final concentrations of 1.0 ϫ 10 6 cells/mL in 24 multiple-well dishes, and 2-mercaptoethanol and phorbol-12 myristate-13 acetate (50 ng/mL) in dimethyl sulfoxide were added for differentiating monocytes from macrophages. Escherichia coli LPS (serotype O55:B5) and phorbol-12 myristate-13 acetate were purchased from Sigma Chemical (St. Louis, MO), while purified HDL was from CALBIOCHEM-NOVABIOCHEM (La Jolla, CA). Trypan blue uptake was used to assess cell viability before incubation, and viability was found to be Ͼ95%.
After 24 hrs of incubation with phorbol-12 myristate-13 acetate, the cells were washed three times with phosphate-buffered saline. Cultures of human macrophages were incubated with LPS (1000 ng/mL) and varying concentrations of HDL cholesterol (0, 1.0 ϫ 10 Ϫ2 , 1.0 ϫ 10 Ϫ1 , 1.0 ϫ 10 0 , and 1.0 ϫ 10 1 mg/dL) either in concomitance or in sequence. In the concomitant group, human macrophages were incubated with LPS and HDL concomitantly for 2 hrs. After being washed three times with phosphate-buffered saline, they were incubated for an additional 24 hrs in fresh medium containing the same concentrations of HDL cholesterol previously used. In the sequential group, human macrophages were first incubated alone with LPS for 2 hrs and then washed three times with phosphate-buffered saline to remove the LPS. They were then incubated for an additional 24 hrs in fresh medium containing various concentrations of HDL cholesterol. TNF-␣ levels were measured in the supernatant at the end of incubation by an enzyme-linked immunosorbent assay (R & D Systems, Minneapolis, MN).
Statistical Analysis. Categorical variables were compared using Fisher's exact test. Differences in continuous variables were analyzed using Wilcoxon's ranksum test. Spearman's rank-correlation coefficient (r) was used to express the correlation between continuous variables, while linear regression was used to estimate correlations between cytokine and lipid levels that were log transformed to reduce skewing in the distribution.
The goodness of fit was expressed as R 2 , while the ability of HDL cholesterol and Apo-AI to predict the overall 30-day mortality rate was evaluated using the receiver operator characteristic curve. Multivariate 
Clinical characteristics, including age, gender, body mass index, preexisting comorbidity, site of infection, laboratory data (levels of serum lipids, albumin, Creactive protein, and bilirubin and prothrombin time), and disease severity (APACHE II score and absence or presence of septic shock) were entered into this multivariate model. Kaplan-Meier survival curves were constructed for the 30-day period after the onset of severe sepsis, and subgroups were compared with log-rank test findings. All of the statistical analyses were performed using Stata version 7 software (College Station, TX). Data are presented as median (range) unless otherwise noted. All reported p values are two sided, and p Ͻ .05 was considered statistically significant.
RESULTS
Patient Characteristics. Of the 306 consecutive patients admitted to the ICU, 167 met the criteria for severe sepsis. Of these patients, 104 were excluded on the basis of the exclusion criteria (31 patients with liver cirrhosis, 27 patients with terminal cancer, 42 patients with a history of hyperlipidemia, and 4 patients receiving total parenteral nutrition during the study); therefore, 63 patients were included in the study. There were 36 men (57%) and 27 women (43%), all of whom were Chinese; the patients' median age was 72 yrs (range, 18 -92 yrs). Their demographic and clinical characteristics are shown in Table 1 .
All patients were severely ill with a median APACHE II score of 28 (range, 15-53). Fifty patients (79%) contracted infections in the community, and 13 patients were admitted due to hospitalacquired infections. Forty-seven patients (75%) had at least two dysfunctional organ systems, and 42 patients (67%) had septic shock. Pulmonary infection was the most common origin of sepsis (60%), while intraabdominal infection ranked second (19%). The prevalence of infections caused by Gram-negative microorganisms (67%) was much higher than that of infections caused by Grampositive microorganisms (11%).
Nineteen patients (30%) died within the 30-day observation period and were classified as "nonsurvivors." The other patients were defined as "survivors." Compared with the survivors, the nonsurvivors were more severely ill with higher APACHE II scores (p Ͻ .01), had a higher number of dysfunctional organ systems (p Ͻ .01), and had a higher proportion of septic shock (p ϭ .02). There were no significant differences between survivors and nonsurvivors in infection sites and sepsis-causing microorganisms.
Lipid Levels and Cytokines. The lipid, lipoprotein, and Apo levels were measured on days 1-4, 7, and 14 of severe sepsis. The levels of HDL cholesterol and Apo-AI in nonsurvivors were significantly lower than those in survivors from days 1 to 4 (Fig. 1) . With the exception of triglyceride levels, which showed a weak positive correlation with both proinflammatory cytokines, an inverse correlation was found between lipids and cytokines on day 1. Among these, HDL cholesterol had the strongest inverse correlation with both cytokines (Fig. 2) .
The power of day 1 HDL cholesterol and Apo-AI levels to predict the overall 30-day mortality rate was assessed with receiver operator characteristic curve analysis (Fig. 3) . The areas under the receiver operator characteristic curve for HDL cholesterol and Apo-AI were 0.84 (95% confidence interval ϭ 0.72-0.96) and 0.87 (95% confidence interval ϭ 0.77-0.98), respectively. An HDL cholesterol cutoff value of 20 mg/dL had a sensitivity of 92%, a specificity of 80%, and an accuracy of 83% for predicting the overall 30-day mortality rate. Similarly, an Apo-AI cutoff value of 100 mg/dL had a sensitivity of 83%, a specificity of 73%, and an accuracy of 76%. Not only the overall 30-day mortality rate but also the attributable mortality rate, the risk of prolonged ICU stay, and the rate of hospital-acquired infection were also increased among patients with low HDL cholesterol (Ͻ20 mg/dL) or low Apo-AI (Ͻ100 mg/dL) levels (Table 2 and Fig. 4) .
Using multivariate analysis, the power of lipids and several clinical characteristics to predict the overall 30-day mortality rate was evaluated. Only HDL cholesterol level of Ͻ20 mg/dL (odds ratio, 12.92; 95% confidence interval, 2.73-61.29) on day 1 and APACHE II score (odds ratio, 1.15; 95% confidence interval, 1.04 -1.26) remained in the final multivariate logistic regression model. Disregarding subgroups with different age, gender, site of contracting infections (community-acquired or hospital-acquired infections), or status of comorbidities, such as diabetes mellitus, patients with HDL levels of Ͻ20 mg/dL consistently had a higher overall 30-day mortality rate than those with HDL levels of Ն20 mg/dL.
HDL and TNF-␣ Induction Assay. The ability of HDL to inhibit LPS-induced TNF-␣ production was examined on cultured human macrophages. LPS-induced TNF-␣ release was attenuated by incremental doses of HDL cholesterol when added simultaneously, with an HDL cholesterol level of Ն1.0 mg/dL significantly inhibiting LPS-mediated TNF-␣ induction (p Ͻ .01) (Fig. 5 , LPS/HDL concomitant group). However, the administration of HDL failed to suppress LPS-induced TNF-␣ production when added after the macrophage had been exposed to LPS ( 
DISCUSSION
This observational study revealed how low levels of HDL cholesterol and Apo-AI on day 1 of severe sepsis are significantly associated with an increase in overall and sepsis-attributable mortality rates, risk of prolonged ICU stay, and hospital-acquired infection rate. Despite some differences in the initial presentations between survivor and nonsurvivor groups, a day 1 HDL cholesterol level of Ͻ20 mg/dL was the independent predictive marker of the overall 30-day mortality rate.
Only a few studies have investigated the ability of HDL cholesterol levels to predict the prognosis of severe sepsis. As shown by Gordon et al. (11, 12) , surgical patients with low lipoprotein levels tended to have a high sepsis-related mortality rate. The beneficial effects of lipoproteins in sepsis may be related to their capability to neutralize Ͼ90% of toxic bacterial substances (including LPS and lipoteichoic acid) (2, 20 -26) . Of all lipoproteins, HDL has the highest LPS and lipoteichoic acid binding capacity (20, 22) . Our study further demonstrated that in patients with low HDL levels, serum concentrations of proinflammatory cytokines (interleukin-6 and TNF-␣) were higher, which reflected the overactive status of the inflammatory response capable of causing tissue damage that lead to multiple organ damage and death (27) .
The diminution of HDL in severe sepsis is well known, but the mechanisms remain unclear (28) . One possibility is that HDL is consumed significantly by binding bacterial substances (20 -22, 25, 26) . Therefore, a high production of endotoxin consumes more HDL and causes a rapid decline of the latter. Another possibility is that high concentrations of proinflammatory cytokines during sepsis suppress lipoprotein production (29, 30) and facilitate lipoprotein degradation (31) . The deficiency in HDL renders the host tissue more susceptible to bacterial substance-mediated injury, resulting in cytokine overproduction and a further depletion of HDL (vicious cycle). In a study by van Leeuwen et al. (28) , HDL cholesterol concentrations in patients with severe sepsis declined rapidly early in the disease process, but discrimination between survivors and nonsurvivors by initial HDL cholesterol concentrations could not be achieved. Moreover, their study was limited by a small sample size. Our results support the hypothesis that a low HDL cholesterol level is associated with unfavorable clinical outcomes in severe sepsis.
In previous reports, the initial decrease of HDL cholesterol levels in severe sepsis recovered to normal concentra- tions in the following days (28) . We found similar results: i.e., during the first 4 days, HDL cholesterol levels were significantly lower in nonsurvivors than in survivors, but the HDL levels in nonsurvivors increased to levels comparable with those in survivors on day 7. The possible mechanisms underlying the recovery of HDL are still unknown.
The major Apo of HDL (Apo-AI) also plays an important role in sepsis. Our results also showed that low levels of Apo-AI on day 1 were significantly associated with an unfavorable outcome.
Chenaud et al. (32) showed that a low Apo-AI level upon ICU admission was associated with an increase in the exacerbation of the systemic inflammatory response syndrome. Emancipator et al. (23) and Flegel et al. (33) found that Apo-AI directly inactivated endotoxin and the protein/endotoxin interaction that may lead to the neutralization of bacterial substances. Therefore, similar to HDL cholesterol, a deficiency of Apo-AI would heighten the susceptibility to an overactive inflammatory response.
Although HDL is known to be capable of binding and neutralizing endotoxin, a problem remains unsolved as to whether HDL can attenuate the inflammatory response through other mechanisms. Our study of cultured macrophages demonstrated that LPS-induced TNF-␣ release could not be suppressed once HDL was administered after LPS exposure. These results indicate that although HDL cholesterol possesses several potential mechanisms to attenuate the chain of inflammation once activated, they actually play only minor roles. Clinically, we found that HDL cholesterol levels only during the early stage (the first 4 days), but not the late stage, of severe sepsis were associated with survival. These findings support the observation that HDL contributes beneficial effects to survival only in the early, but not the late, stage of severe sepsis.
We conclude that a low HDL cholesterol level on day 1 of severe sepsis is significantly associated with an increase in mortality and adverse clinical outcomes. In cultured macrophages, HDL can attenuate LPS-induced TNF-␣ production only if added before, but not after, LPS exposure. It remains unclear whether a lower HDL level in septic patients is only an epiphenomenon or has a causal relationship with sepsis-associated outcomes. It is also unclear whether low HDL cholesterol levels on day 1 of severe sepsis are caused by low baseline HDL levels before sepsis, by higher amounts of endotoxin production during severe infection, or by the suppression of production by proinflammatory cytokines. Further studies performed with prospective and randomized designs are needed to demonstrate the therapeutic benefits, and these investigations may provide a deeper insight into the role of HDL in sepsis. 
